Comparison of Dolutegravir Effectiveness vs. Other Anchor Agent Effectiveness among Hepatitis C Virus Co-infected patients in the OPERA® Observational Database (207833)

Study identification

• EU PAS number:
  EUPAS19875
• Study ID:
  42158
• Official title and acronym:
  Comparison of Dolutegravir Effectiveness vs. Other Anchor Agent Effectiveness among Hepatitis C Virus Co-infected patients in the OPERA® Observational Database (207833)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Finalised

Research institutions and networks

Institutions

ViiV Healthcare

Study timelines

Date when funding contract was signed

Planned: 04/04/2017

Actual: 04/04/2017

Study start date

Planned: 28/07/2017

Actual: 21/07/2017

Data analysis start date

Planned: 27/06/2017

Date of final study report

Planned: 24/10/2018

Actual: 14/02/2018

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

ViiV Healthcare

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable